{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T04:38:48Z","timestamp":1768019928702,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-05739-6","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T08:49:26Z","timestamp":1755766166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A secreted signature discriminates indolent from aggressive prostate tumors"],"prefix":"10.1007","volume":"43","author":[{"given":"Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaona","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kebing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haidong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chutian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yisong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanying","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gengguo","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinming","family":"Di","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"issue":"2","key":"5739_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren O, Pekala KR, Matsoukas K, Fainberg J, Mungovan SF, Bratt O, Bray F, Brawley O, Luckenbaugh AN, Mucci L, Morgan TM, Carlsson SV (2023) 2022 update on prostate cancer epidemiology and risk factors-a systematic review. Eur Urol 84(2):191\u2013206","journal-title":"Eur Urol"},{"issue":"8","key":"5739_CR2","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/s41416-022-01881-9","volume":"127","author":"B Trujillo","year":"2022","unstructured":"Trujillo B, Wu AJ, Wetterskog D, Attard G (2022) Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges. Br J Cancer 127(8):1394\u20131402","journal-title":"Br J Cancer"},{"issue":"6","key":"5739_CR3","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1097\/JU.0000000000001701","volume":"205","author":"P Rajwa","year":"2021","unstructured":"Rajwa P, Pradere B, Mori K, Ploussard G, Leapman MS, Shariat SF (2021) Association of negative followup biopsy and reclassification during active surveillance of prostate cancer: a systematic review and meta-analysis. J Urol 205(6):1559\u20131568","journal-title":"J Urol"},{"issue":"2","key":"5739_CR4","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3390\/clinpract14020039","volume":"14","author":"E Bologna","year":"2024","unstructured":"Bologna E, Ditonno F, Licari LC, Franco A, Manfredi C, Mossack S, Pandolfo SD, De Nunzio C, Simone G, Leonardo C, Franco G (2024) Tissue-based genomic testing in prostate cancer: 10-year analysis of national trends on the use of prolaris, decipher, promark, and oncotype DX. Clinics Pract 14(2):508\u2013520","journal-title":"Clinics Pract"},{"key":"5739_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0561-9","author":"AR Parikh","year":"2019","unstructured":"Parikh AR, Leshchiner I, Elagina L, Goyal L, Levovitz C, Siravegna G, Livitz D, Rhrissorrakrai K, Martin EE, Van Seventer EE, Hanna M, Slowik K, Utro F, Pinto CJ, Wong A, Danysh BP, de la Cruz FF, Fetter IJ, Nadres B, Shahzade HA, Allen JN, Blaszkowsky LS, Clark JW, Giantonio B, Murphy JE, Nipp RD, Roeland E, Ryan DP, Weekes CD, Kwak EL, Faris JE, Wo JY, Aguet F, Dey-Guha I, Hazar-Rethinam M, Dias-Santagata D, Ting DT, Zhu AX, Hong TS, Golub TR, Iafrate AJ, Adalsteinsson VA, Bardelli A, Parida L, Juric D, Getz G, Corcoran RB (2019) Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers. Nature Med. https:\/\/doi.org\/10.1038\/s41591-019-0561-9","journal-title":"Nature Med"},{"key":"5739_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02021-w","author":"LW Ma","year":"2024","unstructured":"Ma LW, Guo HL, Zhao YX, Liu ZB, Wang CR, Bu JH, Sun T, Wei JW (2024) Liquid biopsy in cancer: current status, challenges and future prospects. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-024-02021-w","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"5739_CR7","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1073\/pnas.0530278100","volume":"100","author":"JB Welsh","year":"2003","unstructured":"Welsh JB, Sapinoso LM, Kern SG, Brown DA, Liu T, Bauskin AR, Ward RL, Hawkins NJ, Quinn DI, Russell PJ, Sutherland RL, Breit SN, Moskaluk CA, Frierson HF, Hampton GM (2003) Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc Natl Acad Sci USA 100(6):3410\u20133415","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"5739_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1534\/genetics.112.142810","volume":"193","author":"CK Barlowe","year":"2013","unstructured":"Barlowe CK, Miller EA (2013) Secretory Protein Biogenesis and Traffic in the Early Secretory Pathway. Genetics 193(2):383\u2013410","journal-title":"Genetics"},{"issue":"6","key":"5739_CR9","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1002\/1878-0261.12809","volume":"15","author":"U Landegren","year":"2021","unstructured":"Landegren U, Hammond M (2021) Cancer diagnostics based on plasma protein biomarkers: hard times but great expectations. Mol Oncol 15(6):1715\u20131726","journal-title":"Mol Oncol"},{"key":"5739_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10523-z","author":"JF Li","year":"2023","unstructured":"Li JF, Li JJ, Hao HF, Lu FL, Wang J, Ma ML, Jia B, Zhuo ML, Wang JJ, Chi YJ, Zhai XY, Wang YY, Wu MN, An TT, Zhao J, Yang F, Wang ZP (2023) Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma. Cancer. https:\/\/doi.org\/10.1186\/s12885-023-10523-z","journal-title":"Cancer"},{"key":"5739_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-022-00272-w","author":"RB Ge","year":"2022","unstructured":"Ge RB, Wang ZW, Cheng L (2022) Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance. Precis Oncol. https:\/\/doi.org\/10.1038\/s41698-022-00272-w","journal-title":"Precis Oncol"},{"key":"5739_CR12","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-4028","author":"A El-Kenawi","year":"2021","unstructured":"El-Kenawi A, Viqueira WD, Liu M, Awasthi S, Dhillon J, Yamoah K, Yu XQ, Koomen J, Gatenby R, Ruffell B (2021) Macrophage tumor cell metabolic interactions induce therapeutic resistance in prostate cancer. Cancer Res. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-4028","journal-title":"Cancer Res"},{"issue":"4","key":"5739_CR13","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","volume":"27","author":"B Ruffell","year":"2015","unstructured":"Ruffell B, Coussens LM (2015) Macrophages and therapeutic resistance in cancer. Cancer Cell 27(4):462\u2013472","journal-title":"Cancer Cell"},{"key":"5739_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.634075","author":"N Xu","year":"2021","unstructured":"Xu N, Dong RN, Lin TT, Lin T, Lin YZ, Chen SH, Zhu JM, Ke ZB, Huang F, Chen YH, Xue XY (2021) Development and validation of novel biomarkers related to m2 macrophages infiltration by weighted gene co-expression network analysis in prostate cancer. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2021.634075","journal-title":"Front Oncol"},{"key":"5739_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117002","author":"QN Gu","year":"2024","unstructured":"Gu QN, Qi AN, Wang N, Zhou ZX, Zhou XH (2024) Macrophage dynamics in prostate cancer: molecular to therapeutic insights. Biomed Pharma. https:\/\/doi.org\/10.1016\/j.biopha.2024.117002","journal-title":"Biomed Pharma"},{"issue":"14","key":"5739_CR16","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1002\/pmic.200800979","volume":"9","author":"W Liu","year":"2009","unstructured":"Liu W, Zhou XW, Liu SJ, Hu KH, Wang C, He QY, Li MT (2009) Calpain-truncated CRMP-3 and-4 contribute to potassium deprivation-induced apoptosis of cerebellar granule neurons. Proteomics 9(14):3712\u20133728","journal-title":"Proteomics"},{"key":"5739_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2019.188336","author":"JN Chun","year":"2020","unstructured":"Chun JN, Cho M, Park S, So I, Jeon JH (2020) The conflicting role of E2F1 in prostate cancer: A matter of cell context or interpretational flexibility. Biochimica Et Biophysica Acta-Reviews on Cancer. https:\/\/doi.org\/10.1016\/j.bbcan.2019.188336","journal-title":"Biochimica Et Biophysica Acta-Reviews on Cancer."},{"issue":"2","key":"5739_CR18","doi-asserted-by":"publisher","first-page":"791","DOI":"10.21873\/anticanres.15537","volume":"42","author":"Y Minegishi","year":"2022","unstructured":"Minegishi Y, Hiroshima Y, Yazawa K, Sato S, Yabushita Y, Homma Y, Matsuyama R, Kato I, Goshima Y, Endo I (2022) CRMP4 Up-regulates M2 macrophages and myeloid-derived suppressor cells to promote pancreatic cancer in mice. Anticancer Res 42(2):791\u2013799","journal-title":"Anticancer Res"},{"issue":"2","key":"5739_CR19","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nprot.2006.83","volume":"1","author":"P Chomczynski","year":"2006","unstructured":"Chomczynski P, Sacchi N (2006) The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protoc 1(2):581\u2013585","journal-title":"Nat Protoc"},{"issue":"2","key":"5739_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10549-008-9925-4","volume":"113","author":"LF Li","year":"2009","unstructured":"Li LF, Xu XJ, Zhao Y, Liu ZB, Shen ZZ, Jin WR, Shao ZM (2009) Integrated gene expression profile predicts prognosis of breast cancer patients. Breast Cancer Res Treat 113(2):231\u2013237","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"5739_CR21","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/nbt1210-1248","volume":"28","author":"M Uhlen","year":"2010","unstructured":"Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S, Wernerus H, Bj\u00f6rling L, Ponten F (2010) Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 28(12):1248\u20131250","journal-title":"Nat Biotechnol"},{"issue":"5","key":"5739_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA (2015) Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 12(5):453\u2013457","journal-title":"Nat Methods"},{"key":"5739_CR23","doi-asserted-by":"publisher","DOI":"10.1101\/2023.08.11.553009","author":"SY Cheng","year":"2024","unstructured":"Cheng SY, Li L, Yeh YS, Shi YL, Franco O, Corey E, Yu XP (2024) Unveiling novel double-negative prostate cancer subtypes through single-cell RNA sequencing analysis. Precis Oncol. https:\/\/doi.org\/10.1101\/2023.08.11.553009","journal-title":"Precis Oncol"},{"key":"5739_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.942849","author":"SA Du","year":"2023","unstructured":"Du SA, Zhu C, Ren XL, Chen X, Cui X, Guan S (2023) Regulation of secretory pathway kinase or kinase-like proteins in human cancers. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.942849","journal-title":"Front Immunol"},{"issue":"6","key":"5739_CR25","first-page":"1817","volume":"196","author":"A Atala","year":"2016","unstructured":"Atala A (2016) Mesenchymal stem cells are recruited and activated into carcinoma-associated fibroblasts by prostate cancer microenvironment-derived TGF-\u03b21. J Urol 196(6):1817\u20131817","journal-title":"J Urol"},{"key":"5739_CR26","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.04.064","author":"NR Gough","year":"2021","unstructured":"Gough NR, Xiang XY, Mishra L (2021) TGF-\u03b2 signaling in liver, pancreas, and gastrointestinal diseases and cancer. Gastroenterology. https:\/\/doi.org\/10.1053\/j.gastro.2021.04.064","journal-title":"Gastroenterology"},{"key":"5739_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147575","author":"MKK Chan","year":"2022","unstructured":"Chan MKK, Chung JYF, Tang PCT, Chan ASW, Ho JYY, Lin TPT, Chen JY, Leung KT, To KF, Lan HY, Tang PMK (2022) TGF-\u03b2 signaling networks in the tumor microenvironment. Cancer Lett. https:\/\/doi.org\/10.3390\/ijms22147575","journal-title":"Cancer Lett"},{"issue":"40","key":"5739_CR28","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1038\/sj.onc.1209552","volume":"25","author":"YT Chou","year":"2006","unstructured":"Chou YT, Wang H, Chen Y, Danielpour D, Yang YC (2006) Cited2 modulates TGF-\u03b2-mediated upregulation of MMP9. Oncogene 25(40):5547\u20135560","journal-title":"Oncogene"},{"issue":"15","key":"5739_CR29","first-page":"4632","volume":"63","author":"A Mamoune","year":"2003","unstructured":"Mamoune A, Luo JH, Lauffenburger DA, Wells A (2003) Calpain-2 as a target for limiting prostate cancer invasion. Can Res 63(15):4632\u20134640","journal-title":"Can Res"},{"issue":"9","key":"5739_CR30","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/pros.23512","volume":"78","author":"X Gao","year":"2018","unstructured":"Gao X, Mao YH, Xiao CT, Li K, Liu W, Li LY, Pang J (2018) Calpain-2 triggers prostate cancer metastasis via enhancing CRMP4 promoter methylation through NF-B\/DNMT1 signaling pathway. Prostate 78(9):682\u2013690","journal-title":"Prostate"},{"issue":"4","key":"5739_CR31","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/onc.2015.109","volume":"35","author":"P Adamo","year":"2016","unstructured":"Adamo P, Ladomery MR (2016) The oncogene ERG: a key factor in prostate cancer. Oncogene 35(4):403\u2013414","journal-title":"Oncogene"},{"issue":"6","key":"5739_CR32","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.juro.2017.12.006","volume":"199","author":"RSC Liu","year":"2018","unstructured":"Liu RSC, Olkhov-Mitsel E, Jeyapala R, Zhao F, Commisso K, Klotz L, Loblaw A, Liu SK, Vesprini D, Fleshner NE, Bapat B (2018) Assessment of serum microRNA biomarkers to predict reclassification of prostate cancer in patients on active surveillance. J Urol 199(6):1476\u20131482","journal-title":"J Urol"},{"issue":"10","key":"5739_CR33","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1158\/1078-0432.CCR-18-2849","volume":"25","author":"F Urabe","year":"2019","unstructured":"Urabe F, Matsuzaki J, Yamamoto Y, Kimura T, Hara T, Ichikawa M, Takizawa S, Aoki Y, Niida S, Sakamoto H, Kato K, Egawa S, Fujimoto H, Ochiya T (2019) Large-scale circulating microRNA profiling for the liquid biopsy of prostate cancer. Clin Cancer Res 25(10):3016\u20133025","journal-title":"Clin Cancer Res"},{"issue":"6","key":"5739_CR34","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1158\/1078-0432.CCR-23-3017","volume":"30","author":"S Halabi","year":"2024","unstructured":"Halabi S, Guo S, Park JJ, Nanus DM, George DJ, Antonarakis ES, Danila DC, Szmulewitz RZ, McDonnell DP, Norris JD, Lu C, Luo J, Armstrong AJ (2024) The impact of circulating tumor cell HOXB13 RNA detection in men with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone or enzalutamide. Clin Cancer Res 30(6):1152\u20131159","journal-title":"Clin Cancer Res"},{"issue":"1","key":"5739_CR35","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s12876-024-03447-w","volume":"24","author":"Y Cheng","year":"2024","unstructured":"Cheng Y, Lin X, Xu H, Xu M, Xie W, Zeng J, Cui B, Cheng Z, Zhao J, Sun Y (2024) Integrin \u03b25, a noninvasive diagnostic biomarker, is associated with unfavorable prognosis and immunotherapy efficacy in gastric cancer. BMC Gastroenterol 24(1):362","journal-title":"BMC Gastroenterol"},{"key":"5739_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16223766","author":"P Russo","year":"2024","unstructured":"Russo P, Bizzarri FP, Filomena GB, Marino F, Iacovelli R, Ciccarese C, Boccuto L, Ragonese M, Gavi F, Rossi F, Savoia C, Suraci PP, Falabella R, Pandolfo SD, Napolitano L, Leoni C, Trevisan V, Palermo G, Racioppi M, Sacco E, Muselaers S, Foschi N (2024) Relationship between loss of Y chromosome and urologic cancers: new future perspectives. Cancers. https:\/\/doi.org\/10.3390\/cancers16223766","journal-title":"Cancers"},{"key":"5739_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005532","author":"C Yin","year":"2023","unstructured":"Yin C, Wang M, Wang YZ, Lin QJ, Lin KY, Du H, Lang CD, Dai YH, Peng XS (2023) BHLHE22 drives the immunosuppressive bone tumor microenvironment and associated bone metastasis in prostate cancer. J Immunother Can. https:\/\/doi.org\/10.1136\/jitc-2022-005532","journal-title":"J Immunother Can"},{"key":"5739_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8580043","author":"CL Han","year":"2022","unstructured":"Han CL, Deng YX, Xu WC, Liu Z, Wang T, Wang SG, Liu JH, Liu XM (2022) The Roles of tumor-associated macrophages in prostate cancer. J Oncol. https:\/\/doi.org\/10.1155\/2022\/8580043","journal-title":"J Oncol"},{"issue":"6","key":"5739_CR39","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/s41401-021-00757-7","volume":"43","author":"YQ Chen","year":"2022","unstructured":"Chen YQ, Song HY, Zhou ZY, Ma J, Luo ZY, Zhou Y, Wang JY, Liu S, Han XH (2022) Osthole inhibits the migration and invasion of highly metastatic breast cancer cells by suppressing ITG\u03b13\/ITG\u03b25 signaling. Acta Pharmacol Sin 43(6):1544\u20131555","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"5739_CR40","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/CAD.0000000000001050","volume":"32","author":"W Shi","year":"2021","unstructured":"Shi W, He J, Huang Y, Zeng Z, Feng ZQ, Xu HM, Nie YQ (2021) Integrin \u03b25 enhances the malignancy of human colorectal cancer by increasing the TGF-\u03b2 signaling. Anticancer Drugs 32(7):717\u2013726","journal-title":"Anticancer Drugs"},{"issue":"16","key":"5739_CR41","doi-asserted-by":"publisher","first-page":"5994","DOI":"10.7150\/ijbs.73141","volume":"18","author":"F Shi","year":"2022","unstructured":"Shi F, Sun MH, Zhou Z, Wu L, Zhu Z, Xia SJ, Han BM, Zhao YY, Jing YF, Cui D (2022) Tumor-associated macrophages in direct contact with prostate cancer cells promote malignant proliferation and metastasis through NOTCH1 pathway. Int J Biol Sci 18(16):5994\u20136007","journal-title":"Int J Biol Sci"},{"issue":"8","key":"5739_CR42","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/sj.jid.5700331","volume":"126","author":"Y Asano","year":"2006","unstructured":"Asano Y, Ihn H, Jinnin M, Mimura Y, Tamaki K (2006) Involvement of \u03b1v\u03b25 integrin in the establishment of autocrine TGF-\u03b2 signaling in dermal fibroblasts derived from localized scleroderma. J Investig Dermatol 126(8):1761\u20131769","journal-title":"J Investig Dermatol"},{"issue":"3","key":"5739_CR43","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/cvr\/cvu053","volume":"102","author":"V Sarrazy","year":"2014","unstructured":"Sarrazy V, Koehler A, Chow ML, Zimina E, Li CX, Kato H, Caldarone CA, Hinz B (2014) Integrins \u03b1v\u03b25 and \u03b1v\u03b23 promote latent TGF-\u03b21 activation by human cardiac fibroblast contraction. Cardiovasc Res 102(3):407\u2013417","journal-title":"Cardiovasc Res"},{"key":"5739_CR44","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jneuroim.2017.11.005","volume":"314","author":"HJ Zhang","year":"2018","unstructured":"Zhang HJ, Caudle Y, Wheeler C, Zhou Y, Stuart C, Yao BZ, Yin DL (2018) TGF-\u03b21\/Smad2\/3\/Foxp3 signaling is required for chronic stress-induced immune suppression. J Neuroimmunol 314:30\u201341","journal-title":"J Neuroimmunol"},{"issue":"4","key":"5739_CR45","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","volume":"50","author":"E Batlle","year":"2019","unstructured":"Batlle E, Massagu\u00e9 J (2019) Transforming growth factor-\u03b2 signaling in immunity and cancer. Immunity 50(4):924\u2013940","journal-title":"Immunity"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05739-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-05739-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05739-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:02:47Z","timestamp":1767996167000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-05739-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5739"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-05739-6","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"All study protocols were ethically approved by the ethics Committee of the 3rd Affiliated Hospital of Sun Yat-Sen University, Yue-Dong Hospital of Sun Yat-Sen University, and Shen Zhen She-Kou People\u2019s Hospital. Informed written consent was obtained from all participants involved in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The publication has been approved by all co-authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"506"}}